Detalhe da pesquisa
1.
An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.
Blood
; 129(5): 609-618, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908880
2.
Perspective on a Modified Developmental and Reproductive Toxicity Testing Strategy for Cancer Immunotherapy.
Int J Toxicol
; 35(3): 263-73, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786669
3.
Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics.
Drug Discov Today
; 28(2): 103440, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375739
4.
Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?
Clin Transl Sci
; 15(9): 2096-2104, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35611545
5.
Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors.
MAbs
; 14(1): 1979447, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923919
6.
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.
JCI Insight
; 5(7)2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32271166
7.
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection.
Toxicol Sci
; 169(2): 409-421, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796434
8.
Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys.
Toxicol Sci
; 165(1): 186-197, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893934
9.
Resolution of unexpected pregnancy-related findings in a rat embryofetal development and toxicokinetic study of monoclonal antibodies specific for hCMV.
Birth Defects Res
; 110(18): 1347-1357, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381912
10.
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
Sci Transl Med
; 10(463)2018 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333240
11.
Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Clin Cancer Res
; 12(22): 6808-16, 2006 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17121902
12.
Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine.
Cancer Res
; 65(6): 2449-56, 2005 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15781661
13.
The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
J Leukoc Biol
; 75(6): 962-72, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-14996827
14.
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.
Cancer Cell
; 20(4): 472-86, 2011 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22014573
15.
Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.
J Immunol
; 179(11): 7376-84, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18025181
16.
The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.
Cancer Immunol Immunother
; 55(10): 1285-93, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16408214
17.
Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
J Immunother
; 29(4): 367-80, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16799332
18.
OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent.
J Immunol
; 171(11): 5997-6005, 2003 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14634111